AIM-listed drug discovery and development firm Redx Pharma has appointed Dr Jane Robertson as Chief Medical Officer.  Robertson, a well respected UK haemato-oncologist with over 17 years’ experience of clinical development in oncology, will commence her role at the cancer and fibrosis focused firm in March 2021. She joins the firm form Achilles Therapeutics, a … Continue reading BioTech firm Redx Pharma appoints Chief Medical Officer